| MADRIGAL PHARMACEUTICALS |
| USA |
| Gesundheit |
| US5588681057 / A2APCZ |
| YDO1 (Frankfurt) / MDGL (NASDAQ) |
| FRA:YDO1, ETR:YDO1, YDO1:GR, NASDAQ:MDGL |
| - |
| https://www.madrigalpharm.. |
|
Madrigal Pharmaceuticals, Inc. is a biopharmaceuti..
>Volltext.. |
| 9956.64 Mio. EUR |
| 9300.77 Mio. EUR |
| 636 Mio. EUR |
| -262.77 Mio. EUR |
| -248.28 Mio. EUR |
| -11.17 EUR |
| 297.46 Mio. EUR |
| 258.21 Mio. EUR |
| -137.89 Mio. EUR |
| 2.85 |
| 814.89% |
| 47.11% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 22.712.698 USD. |
| MADRIGAL |
| 14.01.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|